Scopolamine System
NDC Package 0591-2258-04

11-digit billing NDC: 00591225804 · Billing unit: EA · 4 EA per package

Package Information

Scopolamine systems is scopolamine transdermal system is indicated in adults for the prevention of:nausea and vomiting associated with motion sickness.post-operative nausea and vomiting (PONV) associated with recovery from anesthesia and/or opiate analgesia and surgery. This formulation utilizes a system delivery system. Marketed by Actavis Pharma, Inc., this product is identified by NDC 0591-2258 and is authorized under FDA application ANDA208769.

Identification & Billing

NDC Package Code
0591-2258-04
Package Description
4 POUCH in 1 CARTON / 1 PATCH in 1 POUCH / 3 d in 1 PATCH
Product Code
11-Digit Billing Format
00591225804
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
4 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Scopolamine
Non-Proprietary Name
Scopolamine
Substance Name
Scopolamine
Dosage Form
System -
Administration Route
Transdermal - Administration through the dermal layer of the skin to the systemic circulation by diffusion.
Active Ingredient(s)
Usage Information
Scopolamine transdermal system is indicated in adults for the prevention of:nausea and vomiting associated with motion sickness.post-operative nausea and vomiting (PONV) associated with recovery from anesthesia and/or opiate analgesia and surgery.

Regulatory & Marketing

Labeler Name
Actavis Pharma, Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA208769
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-12-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0591-2258). Click a package code to view its specific billing and regulatory data.

24 POUCH in 1 CARTON / 1 PATCH in 1 POUCH / 3 d in 1 PATCH
10 POUCH in 1 CARTON / 1 PATCH in 1 POUCH / 3 d in 1 PATCH

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0591-2258-04 identifies a specific commercial package of 4 pouch in 1 carton / 1 patch in 1 pouch / 3 d in 1 patch of Scopolamine, a human prescription drug labeled by Actavis Pharma, Inc.. This system is formulated for transdermal use and contains scopolamine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Actavis Pharma, Inc. on May 12, 2022. The current certification is valid through December 31, 2026.

How is this Actavis Pharma, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00591225804. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 4 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0591-2258-04
11-Digit CMS (5-4-2)
00591-2258-04

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.